Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

520
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
520

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA Repair Exhaustion Activates Orthocaspase-Mediated Cell Death and Promote Inclusive Fitness of Cyanobacterial Population Under Abiotic Stress.

Plant, cell & environment·2026
Same author

Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy.

Expert opinion on drug delivery·2026
Same author

In Reply: Optimizing Endoscopic Approaches for Sphenoid Lateral Recess Cerebrospinal Fluid Leaks: Proposal of a New Algorithm.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Qualitative Study of Pharmacy Preceptors and Students' Experiences of Experiential Education During Alberta Wildfires 2023-2024.

American journal of pharmaceutical education·2026
Same author

Vogt-Koyanagi-Harada Disease with Oral Manifestations: A Rare Case Report.

Contemporary clinical dentistry·2026
Same author

Retraction notice to "Bioactive compounds and their libraries: An insight into prospective phytotherapeutics approach for oral mucocutaneous cancers" [Biomedicine & Pharmacotherapy 141 (2021) 111809].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

784

Multiple Sclerosis: Pathogenesis Mechanism and Biomarkers.

Ashwani Arya1, Manish Dhall2, Vineet Mittal3

  • 1Department of Pharmaceutical Education and Research, South Campus, Bhainswal Kalan, Bhagat Phool Singh Mahila Vishwavidyalaya, Khanpur Kalan, Sonepat, Haryana, India.

Central Nervous System Agents in Medicinal Chemistry
|September 5, 2024
PubMed
Summary

Multiple sclerosis (MS) is a central nervous system (CNS) neurodegenerative disease. This review highlights key biomarkers for MS, offering potential therapeutic targets for effective treatment.

Keywords:
CNSMultiple sclerosisbiomarkers.brainimmune systemneurodegeneration

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

784
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Area of Science:

  • Neurology
  • Neuroimmunology
  • Neurodegeneration

Background:

  • Multiple sclerosis (MS) is a chronic, inflammatory, and neurodegenerative disease of the Central Nervous System (CNS).
  • It is characterized by neurological symptom fluctuations and progressive disability.
  • The exact etiology of MS remains undefined, necessitating further research into its pathophysiology.

Purpose of the Study:

  • To provide a concise overview of MS disease activity, progression, and pathogenesis.
  • To emphasize the role of biomarkers in MS as potential therapeutic targets.
  • To identify novel therapeutic interventions for MS.

Main Methods:

  • A comprehensive literature survey was conducted using major scientific websites and search engines.
  • Key research papers and reviews on MS pathogenesis and biomarkers were analyzed.
  • Information on pathological hallmarks and therapeutically valuable biomarkers was synthesized.

Main Results:

  • Pathological hallmarks of MS include cortical inflammation, neurodegeneration, demyelination, axonal injury/loss, and glial activation.
  • Numerous biomarkers such as CNS neurofilaments, GFAP, CXCL13, and miRNAs are identified.
  • These biomarkers are crucial for understanding disease mechanisms and developing targeted therapies.

Conclusions:

  • Understanding MS pathophysiology and identifying specific biomarkers are critical for therapeutic intervention.
  • Biomarkers can aid in identifying at-risk individuals and improving treatment efficacy for progressive MS.
  • Further research into MS biomarkers holds promise for advancing treatment strategies and patient outcomes.